Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The study is carried-out to describe and compare the plasma pharmacokinetics of levodopa and
carbidopa after oral single-dose administration of 100 mg levodopa plus 25 mg carbidopa by
means two fixed combination products (test: Isicom® 100/25 mg; reference: Nacom® 100/25 mg).
Additionally, to describe and compare the safety and tolerability of the two investigational
treatments administered to healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Desitin Arzneimittel GmbH
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa